Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Johnson

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
BMJ Open|January 29, 2014
Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkersKinga Malottki, Mousumi Biswas, Jonathan J Deeks, et al.
Liver Cancer|October 11, 2023
Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature ReviewArndt Vogel, Robin K Kelley, Philip Johnson, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 27, 2023
European' health care indicators and pancreatic cancer incidence and mortality: A mediation analysis of Eurostat data and Global Burden of Disease Study 2019Alessandro Cucchetti, Philip Johnson, Gabriele Capurso, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 27, 2021
Report on 2020 Safe to Touch Consensus Conference on Hazardous Drug Surface ContaminationMichael Gabay, Philip Johnson, John Fanikos, et al.
Annals of Surgical Oncology|February 1, 2008
Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapyMelanie B Thomas, James P O'Beirne, Junji Furuse, et al.
COPD|February 9, 2008
Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary diseaseGerard J Criner, Amir Sharafkhaneh, Rick Player, et al.
Journal of Hepatology|May 30, 2021
Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinomaRuwanthi Kolamunnage-Dona, Sarah Berhane, Harry Potts, et al.
Future Oncology (London, England)|October 8, 2019
Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trialsGiuseppe Cabibbo, Alessandro Cucchetti, Calogero Cammà, et al.
Heart, Lung & Circulation|July 3, 2007
Antioxidant properties of the internal thoracic artery and the radial arteryOmar Mangoush, Thanos Athanasiou, Koki Nakamura, et al.
BMC Medical Research Methodology|April 9, 2025
Estimating treatment effects using parametric models as counter-factual evidenceRichard Jackson, Philip Johnson, Sarah Berhane, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
BMJ Open|January 29, 2014
Stratified medicine in European Medicines Agency licensing: a systematic review of predictive biomarkersKinga Malottki, Mousumi Biswas, Jonathan J Deeks, et al.
Liver Cancer|October 11, 2023
Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature ReviewArndt Vogel, Robin K Kelley, Philip Johnson, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|September 27, 2023
European' health care indicators and pancreatic cancer incidence and mortality: A mediation analysis of Eurostat data and Global Burden of Disease Study 2019Alessandro Cucchetti, Philip Johnson, Gabriele Capurso, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 27, 2021
Report on 2020 Safe to Touch Consensus Conference on Hazardous Drug Surface ContaminationMichael Gabay, Philip Johnson, John Fanikos, et al.
Annals of Surgical Oncology|February 1, 2008
Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapyMelanie B Thomas, James P O'Beirne, Junji Furuse, et al.
COPD|February 9, 2008
Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary diseaseGerard J Criner, Amir Sharafkhaneh, Rick Player, et al.
Journal of Hepatology|May 30, 2021
Sorafenib is associated with a reduced rate of tumour growth and liver function deterioration in HCV-induced hepatocellular carcinomaRuwanthi Kolamunnage-Dona, Sarah Berhane, Harry Potts, et al.
Future Oncology (London, England)|October 8, 2019
Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trialsGiuseppe Cabibbo, Alessandro Cucchetti, Calogero Cammà, et al.
Heart, Lung & Circulation|July 3, 2007
Antioxidant properties of the internal thoracic artery and the radial arteryOmar Mangoush, Thanos Athanasiou, Koki Nakamura, et al.
BMC Medical Research Methodology|April 9, 2025
Estimating treatment effects using parametric models as counter-factual evidenceRichard Jackson, Philip Johnson, Sarah Berhane, et al.
Pageof 10